REQUEST A DEMO

New Report: Launch Readiness 2022 - How to address key trends and challenges

Posted by Andre Moa on Feb 1, 2022 10:30:00 AM

In our new report  Launch Readiness 2022, we consider how launch strategists may best navigate a fast-changing yet still commercially ripe environment for pharmaceutical launch readiness. We show how digital transformation and cutting-edge launch management software help companies track the status of launch activities and manage global launch challenges, in real-time and across both functions and countries.

Read More

Topics: launch readiness, launch strategy, launch effectiveness, launch readiness framework, launch plan, pharma tenders

8 Pharma Trends for 2022: Towards a more holistic understanding of value

Posted by Andre Moa on Dec 8, 2021 11:46:11 AM

After another tough year of COVID-19 restrictions, there were some welcome signs of recovery in late 2021. Also emerging, though, were concerns about new viral variants - most recently, Omicron - that could push up hospitalisations and death tolls, ultimately returning countries to lockdown. In this uncertain climate, as we look ahead to significant pharma trends for 2022, people all over the world are having to re-assess the relationship between their personal health, behaviour and freedoms; and their responsibilities towards the health of their communities and of society at large. That is always a delicate balance.

 

Read More

Topics: Pharma trends, launch trends, launch readiness, AI

Rethinking Launch Readiness in 2021: The New Normal in the Shadow of COVID

Posted by Andre Moa on Feb 24, 2021 3:50:37 PM

 

It is probably reasonable enough by now to talk about the launch readiness landscape for medicines and vaccines as pre- and post-COVID. We can also say with some certainty that nothing will ever be the same again.

Read More

Topics: launch readiness, launch strategy, launch effectiveness, launch readiness framework, launch plan, pharma tenders

5 Pharma Trends for 2021: Disruption and Transformation in the COVID Era

Posted by Andre Moa on Dec 3, 2020 5:43:38 PM

The COVID-19 pandemic has eclipsed every other development in healthcare and pharmaceuticals during 2020. It will likely do so next year as well. Looking ahead to 5 pharma trends for 2021 that will set the agenda for industry, it is hard to escape COVID-19 both as a challenge and a spur to new directions.

 

Read More

Topics: Pharma trends, launch trends, launch readiness, AI

2020 New Drug Approvals: Review of New FDA and EMA Marketing Authorisations

Posted by Andre Moa on Nov 17, 2020 11:21:59 AM

 

Any fears that COVID-19 might stem the flow of new drug approvals in 2020, depleting or diverting resources at regulatory agencies and their pharmaceutical clients, appear largely premature.

Read More

Topics: Pharma launch planning, launch readiness, EMA Approvals, FDA Approvals